Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer

Neutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but point-of-care methods for assessing NAb titer are not widely available. Here, we present a lateral flow assay that captures SARS-CoV-2 receptor-bindi...

Full description

Bibliographic Details
Main Authors: Connelly, Guinevere G, Kirkland, Orville O, Bohannon, Seven, Lim, Daniel C, Wilson, Robert M, Richards, Edward J, Tay, Dousabel M, Jee, Hyuk, Hellinger, Riley D, Hoang, Ngoc K, Hao, Liang, Chhabra, Arnav, Martin-Alonso, Carmen, Tan, Edward KW, Koehler, Angela N, Yaffe, Michael B, London, Wendy B, Lee, Pui Y, Krammer, Florian, Bohannon, Robert C, Bhatia, Sangeeta N, Sikes, Hadley D, Li, Hojun
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:English
Published: Elsevier BV 2023
Online Access:https://hdl.handle.net/1721.1/147025

Internet

https://hdl.handle.net/1721.1/147025

Similar Items